Articles
Construction of Vasoactive Intestinal Peptide Encoding Lentiviral Gene Therapy Vector for Retinal Dystrophies
MOLECULAR THERAPY, vol.29, no.4, pp.266, 2021 (SCI-Expanded, Scopus)
Vasoactive Intestinal Peptide-mediated Gene Therapy for Diabetes
JOURNAL OF THE PANCREAS, no.15, pp.534, 2014 (Peer-Reviewed Journal)
Construction and Evaluation of Lentiviral Vectors Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
ENDOCRINE REVIEWS, vol.35, no.3, 2014 (SCI-Expanded, Scopus)
Downregulation of Vasoactive Intestinal Peptide Expression in Type 2 Diabetes
DIABETES, vol.62, 2013 (SCI-Expanded, Scopus)
Papers Published in Refereed Scientific Meetings
LentiVİP Gen Nakli Tip 1 Diyabetik Deneklerde Sistemik Enflamasyonu Baskılayarak Kan Şekerini Düşürdü
16. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Turkey, 27 - 30 October 2019, pp.1, (Full Text)
LentiVIP delivery suppresses systemic inflammation which results in beneficial outcome in Type 1 Diabetes
ESGCT 27th Annual Congress in collaboration with SETGyc, Barcelona, Spain, 22 - 25 October 2019, pp.1, (Full Text)
Diyabet Hastalığına Karşı Geliştirilen İnsan Vasoaktif İntestinal Peptid Kodlayan HIV tabanlı Gen Tranasfer Vektörlerinin Yapımı ve Testi
50. Ulusal Diyabet Kongresi, Antalya, Turkey, 23 - 27 April 2014, pp.168, (Summary Text)
Generation of A Lentiviral Vector Encoding Human Glucagon Like Peptide-1 (GLP-1) for Diabetes Treatment
ESGCT AND NVGCT COLLABORATIVE CONGRESS, 2014, The Hauge, Amsterdam, Netherlands, 23 - 26 October 2014, vol.25, no.11, pp.87-88, (Full Text)
Obese and diabetic sprague dawley rats exhibited reduced GLP-1 expression in pancreatic islets of Langerhans
ESGCT and FSGCT Collaborative Congress,2015, Helsinki, Finland, 17 - 20 September 2015, (Full Text)
C57BL6J FARELERDE DİYABET İNDÜKSİYONU PANKREAS KÖKENLİ GLP-1 SENTEZİNİ ARTTIRDI
50. Ulusal Diyabet Kongresi, Antalya, Turkey, 23 - 27 April 2014, pp.166, (Summary Text)
Therapeutic efficacy of an HIV-based lentivirus mediated vasoactive intestinal peptide gene delivery for diabetes
ESGCT and NVGCT Collaborative Congress, The Hague, Netherlands, 23 - 26 October 2014, vol.25, (Summary Text)
Up Regulation of Glucagon Like Peptide-1 Expression in Pancreases of C57BL6j Mice with Diabetes
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Netherlands, 23 - 26 October 2014, (Full Text)
Tip 2 diyabet deney hayvan modelinde diyabet induksiyonu adaciklarda vazoaktif intestinal peptid azalimiyla korelasyon gosterdi
49. Ulusal Diyabet Kongresi, Antalya, Turkey, 17 - 21 April 2013, pp.20, (Summary Text)
Therapeutic outcomes of an HIV-based lentivirus mediated Glucagon-like peptide-1 gene delivery for diabetes treatment
ESGCT and FSGCT Collaborative Congress, Helsinki, Finland, 17 - 20 September 2015, (Full Text)
Construction of A Lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
Human Gene TherapyESGCT and NVGCT Collaborative Congress, The Hague, Netherlands, 23 - 26 October 2014, pp.123, (Full Text)
Diyet bağımlı obez Sprague Dawley sıçanlarda STZ ile diyabet indüksiyonu pankreatik adacıklarda inkretin hormonu (GLP-1) sentezini azaltır
51. Ulusal Diyabet Kongresi, Antalya, Turkey, 22 - 26 April 2015, pp.146, (Summary Text)
Diyabet hastalığına karşı geliştirilen insan vazoaktif intestinal peptid kodlayan HİV tabanlı gen transfer vektörlerinin yapımı ve testi
50. Ulusal Diyabet Kongresi, Antalya, Turkey, 23 - 27 April 2014, pp.12, (Summary Text)
Pancreatic expression profiles of vasoactive intestinal peptide and its receptors in mouse model of type 2 diabetes
Collaborative Congress of the European-Society-for-Gene-and-Cell-Therapy and the Spanish Society for Gene and Cell Therapy, Madrid, Spain, 25 - 28 October 2013, vol.24, no.12, pp.138, (Full Text)
Tip 1 diyabet için vazoaktif intestinal peptidi kodlayan lentiviral vektörün geliştirilmesi
15. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Turkey, 26 - 29 October 2017, pp.1, (Full Text)
LentiVIP delivery suppresses systemic inflammation which results in beneficial outcome in Type 1 Diabetes
ESGCT 27th Annual Congress in collaboration with SETGyc Meeting, Barcelona, Spain, 22 - 25 October 2019, vol.30, (Summary Text)
Generation of a lentiviral vector encoding vasoactive intestinal peptide for type 1 diabetes
European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress, Berlin, Germany, 01 January 2017, vol.28, (Summary Text)
Generation of A Lentiviral Vector Encoding Human Glucagon Like Peptide-1 (GLP-1) for Diabetes Treatment
ESGCT and NVGCT Collaborative Congress, The Hague, Netherlands, 23 - 26 October 2014, vol.25, (Summary Text)
Restoration of Pancreatic Beta Cell Mass and Function by GLP-1 Gene Delivery for Diabetes
Beta Cells in Health and Disease, Kocaeli, Turkey, 21 - 23 May 2014, pp.1, (Full Text)
İnkretin gen nakli diyabetik deneklerde insülin direncini kırıp glukoz toleransını geliştirerek beta hücre rejenerasyonu sağlar
53. Ulusal Diyabet Kongresi, Girne, Cyprus (Kktc), 19 - 23 April 2017, pp.250, (Summary Text)
Glucagon like peptide-1 gene delivery increases beta cell replication and neogenesis in Type 2 Diabetic Obese Sprague Dawley Rats
Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy, Florence, Italy, 18 - 21 October 2016, vol.27, (Summary Text)
Downregulation of Vasoactive Intestinal Peptide Expression in Type 2 Diabetes
Congress of American Diabetes Association, Chicago, United States Of America, 21 - 25 June 2013, vol.62, pp.2258, (Summary Text)
HİV tabanlı Lentivirus aracılı Vazoaktif İntestinal Peptid gen nakli obez farelerde insulin direncini kırıp glukoz toleransı geliştirerek STZ indüklü diyabet gelişimini durdurdu
51. Ulusal Diyabet Kongresi, Antalya, Turkey, 22 - 26 April 2015, (Full Text)
Diyabet tedavisi için insan Glukagon Benzeri Peptid-1 kodlayan lentiviral vektörlerin üretimi
51. Ulusal Diyabet Kongresi, Antalya, Turkey, 22 - 26 April 2015, (Summary Text)
Potential Therapeutic Role of Vasoactive Intestinal Peptide in Diabetes
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy/French-Society-of-Cell-and-Gene-Therapy, Versailles, France, 25 - 29 October 2012, vol.23, (Summary Text)
Construction of A lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
EMBO Workshop, Evry, France, 30 March - 04 April 2015, pp.185, (Full Text)
Vasoactive intestinal peptide gene delivery for diabetes treatment
Molecular Biologu and Genetics Congress, İstanbul, Turkey, 2 - 04 October 2015, pp.10, (Summary Text)
Generation of a lentiviral vector encoding vasoactive intestinal peptide for type 1 diabetes
European Society of Gene and Cell Therapy (ESGCT) XXV Anniversary Congress, Berlin, Germany, 17 - 20 October 2017, pp.1, (Full Text)
Diyabette Vazoaktif Intestinal Peptidin terapotik rolü
49. Ulusal Diyabet Kongresi, Antalya, Turkey, 17 - 21 April 2013, pp.12, (Summary Text)
Diyabet Tedavisinde inkretin tabanlı gen tedavi stratejileri.
Uluslararası Katılımlı 12. Ulusal Tıbbi Genetik Kongresi, İzmir, Turkey, 5 - 09 October 2016, vol.2, pp.67-68, (Full Text)
Glucagon like peptide-1 gene delivery increases beta cell replication and neogenesis in Type 2 Diabetic Obese Sprague Dawley Rats
Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy., Floransa, Italy, 18 - 21 October 2016, vol.27, no.11, (Full Text)
Therapeutic outcomes of an HIV-based lentivirus mediated Glucagon-like peptide-1 gene delivery for diabetes treatment
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy (ESGCT) and Finnish-Society-of-Gene-Therapy (FSGT), Helsinki, Finland, 17 - 20 September 2015, vol.26, (Summary Text)
3. Jenerasyon Lentivirus aracılı Vazoaktif İntestinal Peptid gen naklinin obezite bağımlı Tip 2 Diyabet deney hayvan modelinde terapötik etkinliği
14. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Turkey, 27 - 30 October 2015, (Full Text)
İnkretin gen nakli diyabetik deneklerde insülin direncini kırıp glukoz toleransını geliştirerek beta hücre rejenerasyonu sağlar
53. Ulusal Diyabet Kongresi, Girne, Turkey, 19 - 23 April 2017, pp.10, (Full Text)
Glucagon like peptide-1 as an antidiabetic gene therapy agent inducing transdifferantiation of pancreatic endocrine cells
European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress, Berlin, Germany, 01 January 2017, vol.28, (Summary Text)
Diyabet tedavisinde inkretin tabanlı gen transfer stratejilerinin yeri
50. Ulusal Diyabet Kongresi, Antalya, Turkey, 23 - 27 April 2014, (Full Text)
Obese and diabetic sprague dawley rats exhibited reduced GLP-1 expression in pancreatic islets of Langerhans
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy (ESGCT) and Finnish-Society-of-Gene-Therapy (FSGT), Helsinki, Finland, 17 - 20 September 2015, vol.26, (Summary Text)
Books & Book Chapters
Diyabet tedavisinde inkretin tabanlı gen tedavi stratejileri
in: Geçmişten Geleceğe Diabetes Mellitus, İmamoğlu Ş., Satman İ., Akalın S., Salman S., Yılmaz C., Editor, Türkiye Endokrinoloji Ve Metabolizma Der Yayınları, Ankara, pp.603-614, 2015